Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice
- PMID: 6852458
Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice
Abstract
The cumulative risk of developing colon cancer in patients with ulcerative colitis has been stated to increase 10%-20% for every decade of duration of disease after 10 yr. We reviewed the clinical course of 673 patients with inflammatory bowel disease restricted to the colon who were seen by the authors since 1955. A subset of 258 patients with a diagnosis of ulcerative colitis established before 1970 and followed by the authors was studied by both the classical life table and a generalized approach to estimate the risk of colorectal carcinoma. Only nine instances of colorectal carcinoma occurred. Using the former method and eliminating 3 patients referred with known colorectal carcinoma, the actuarial risk for developing this complication for all patients, regardless of extent of disease, was computed to be only 6.6% at 26 yr and 11.4% at 32 yr following the onset of ulcerative colitis. The cumulative probability of colorectal carcinoma among patients with universal colitis at 26 yr was 19.7% by the generalized method and 11.6% using the standard life table. The generalized approach consistently gave higher risk estimates due to a smaller number of patients in the denominator of the risk calculation. Using an alternative method, we calculated cancer risk from the date first seen for patients with universal extent and a history of greater than or equal to 10 yr of disease (means = 17.4 yr). The magnitude of the resulting colorectal carcinoma risk was even less than previously reported in hospitalized patients. This method is more suited for colorectal carcinoma risk assessment of a large series of ulcerative colitis patients seen in private practice and the results should modify the fear of cancer development in these patients.
Similar articles
-
[The pathogenesis of ulcerative colitis-associated colorectal cancer].Magy Onkol. 2004;48(1):35-43. Epub 2004 Apr 23. Magy Onkol. 2004. PMID: 15105894 Review. Hungarian.
-
Chronic inflammatory bowel disease and cancer.Hepatogastroenterology. 2000 Jan-Feb;47(31):57-70. Hepatogastroenterology. 2000. PMID: 10690586 Review.
-
Colorectal cancer complicating ulcerative colitis: an institutional series.J Exp Clin Cancer Res. 1999 Mar;18(1):29-32. J Exp Clin Cancer Res. 1999. PMID: 10374673
-
Ulcerative colitis and colorectal cancer. A population-based study.N Engl J Med. 1990 Nov 1;323(18):1228-33. doi: 10.1056/NEJM199011013231802. N Engl J Med. 1990. PMID: 2215606
-
Cancer in universal and left-sided ulcerative colitis: factors determining risk.Gastroenterology. 1979 Aug;77(2):290-4. Gastroenterology. 1979. PMID: 447042
Cited by
-
Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties.Oncotarget. 2016 Aug 16;7(33):52928-52939. doi: 10.18632/oncotarget.10608. Oncotarget. 2016. PMID: 27447967 Free PMC article.
-
Primary sclerosing cholangitis and the risk of colon neoplasia in patients with Crohn's colitis.Gastroenterol Rep (Oxf). 2016 Aug;4(3):226-31. doi: 10.1093/gastro/gov007. Epub 2015 Feb 26. Gastroenterol Rep (Oxf). 2016. PMID: 25725040 Free PMC article.
-
Quality indicators for colonoscopy.Am J Gastroenterol. 2015 Jan;110(1):72-90. doi: 10.1038/ajg.2014.385. Epub 2014 Dec 2. Am J Gastroenterol. 2015. PMID: 25448873 No abstract available.
-
Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn's disease.Gastroenterol Rep (Oxf). 2016 Feb;4(1):43-9. doi: 10.1093/gastro/gou074. Epub 2014 Oct 29. Gastroenterol Rep (Oxf). 2016. PMID: 25355801 Free PMC article.
-
Colorectal cancer risk in Crohn's disease.World J Gastroenterol. 2008 Mar 28;14(12):1810-1. doi: 10.3748/wjg.14.1810. World J Gastroenterol. 2008. PMID: 18350616 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical